Recom Managed Systems Hires Executives to Lead the Company's Marketing and Information-Systems Organizations

Recom Managed Systems, Inc. (AMEX:RSY), a life-sciences
company developing patented heart-monitoring technology, today
announced the appointments of three key executives to its growing
management team. Jane Greene joins the company as the vice president
of market development; Claire Mouton LaFrance joins as director of
marketing and communications; and Stan Gelfer as director of
information systems.
   "We're excited to welcome Jane, Claire and Stan to spearhead the
development of Recom's marketing and management information systems
(MIS) organizations," said Pamela Bunes, president and chief executive
officer of Recom. "Jane's background in the medical-monitoring
industry will be a great asset as we seek to commercialize our
proprietary technology, and Claire's expertise in physician relations
and communications will be invaluable as we move to establish this
technology with the medical community. Furthermore, Stan's expertise
in project management and MIS development is already proving critical
to the creation of our infrastructure."
   Prior to joining the company, Ms. Greene founded two
medical-monitoring companies, serving as chief executive officer,
president and chairman of the board for both Monitor Medx, a
cardiac-monitoring company, and Medical Resource Management, a
perinatal home monitoring company.
   Most recently, Ms. LaFrance was employed as corporate sales
manager and physician liaison for Greenville Hospital System. In these
roles, she established, staffed and trained the sales department;
negotiated acquisitions of private physician practices by the hospital
system; and served as intermediary between physicians and hospital
administration. She also was responsible for public relations
activities, including planning and execution of community events.
   Mr. Gelfer was previously a senior project manager of strategic
business development at Countrywide Financial Services, Inc. He has
held senior MIS positions at several corporations, including Amgen,
Warner Brothers and Disney.
   "Recom's Model 100 Heart Monitor has the potential to transform
the way physicians diagnose and treat cardiac patients," said Ms.
Bunes. "I look forward to working with this outstanding team of
professionals as we work to build a successful launch and marketing
program for this innovative technology."

   Breakthrough ECG Monitoring Technology

   Recom's first product, the Model 100 Heart Monitor, is an
ambulatory patient heart monitor that uses patented signal-processing
technology to record a clinical-quality ECG signal in the presence of
"noise," or interference, generated by the patient's body movements
and ambient environment. By reducing these interfering factors during
recordings, the Recom Model 100 helps family practitioners, internists
and cardiologists more accurately detect cardiac abnormalities or
changes that may occur during daily activities and allows medical
experts to collect extensive, continuous cardiac data over time, which
can establish a baseline against which future readings can be
compared. The Model 100 provides up to 48 hours of real-time heart
monitoring during patients' everyday activities. The Model 100 has
received 510(k) clearance from the Food and Drug Administration.

   About Recom Managed Systems, Inc.

   Recom Managed Systems, Inc. is an emerging life sciences company
focused on the monitoring and detection of disease through continuous
biomedical signal monitoring. Recom Managed Systems, Inc. uses its
patented signal technology to design and develop medical devices that
simplify and reduce the costs of diagnostic testing and patient
monitoring in an ambulatory setting. With our patented
signal-technology platform, Recom brings clinical-quality
physiological signal monitoring to the ambulatory setting.
   Recom Managed Systems, Inc. has its corporate headquarters in
Greenville, S.C., and research and development facilities in Studio
City, Calif. Recom is traded on the American Stock Exchange under the
symbol RSY. More information is located at
http://www.recom-systems.com.

   Caution Regarding Forward-Looking Statements

   Statements in this release that are not strictly historical are
"forward-looking" statements. Forward-looking statements involve known
and unknown risks, which may cause Recom's actual results in the
future to differ materially from expected results. Factors which could
cause or contribute to such differences include, but are not limited
to, failure to complete the development and introduction of new
products or services, failure to obtain federal or state regulatory
approvals governing medical devices, monitoring and other related
services or products, inability to obtain physician, patient or
insurance acceptance of Recom's products or services, adverse
equity-market conditions and declines in the value of Recom's common
stock, and the unavailability of financing to complete management's
plans and objectives. These risks are qualified in their entirety by
cautionary language and risk factors set forth and to be further
described in Recom's filings with the Securities and Exchange
Commission.